Andrew Booth
2021
In 2021, Andrew Booth earned a total compensation of $4.3M as Chief Financial Officer at AbCellera Biologics.
Compensation breakdown
| Bonus | $159,489 |
|---|---|
| Option Awards | $3,749,818 |
| Salary | $400,000 |
| Other | $4,080 |
| Total | $4,313,387 |
Booth received $3.7M in option awards, accounting for 87% of the total pay in 2021.
Booth also received $159.5K in bonus, $400K in salary and $4.1K in other compensation.
Rankings
In 2021, Andrew Booth's compensation ranked 3,076th out of 12,415 executives tracked by ExecPay. In other words, Booth earned more than 75.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,076 out of 12,415 | 75th |
Division Manufacturing | 1,232 out of 5,508 | 78th |
Major group Chemicals And Allied Products | 496 out of 2,378 | 79th |
Industry group Drugs | 438 out of 2,099 | 79th |
Industry Pharmaceutical Preparations | 298 out of 1,549 | 81st |
Source: SEC filing on April 28, 2022.
Booth's colleagues
We found four more compensation records of executives who worked with Andrew Booth at AbCellera Biologics in 2021.